(Q44411609)

2 December 2017

title

Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients (English)

1 reference

2 December 2017

main subject

cardiovascular disease

1 reference

7

Raymond Vanholder

1 reference

2 December 2017

Sophie Liabeuf

1

1 reference

2 December 2017

Aurélie Lenglet

2

1 reference

2 December 2017

Lucie Desjardins

3

1 reference

2 December 2017

Nathalie Neirynck

4

1 reference

2 December 2017

Griet Glorieux

5

1 reference

2 December 2017

Horst-Dieter Lemke

6

1 reference

2 December 2017

Momar Diouf

8

1 reference

2 December 2017

Gabriel Choukroun

9

1 reference

2 December 2017

Ziad A Massy

10

1 reference

2 December 2017

European Uremic Toxin Work Group (EUTox)

11

1 reference

2 December 2017

language of work or name

English

0 references

publication date

15 August 2012

1 reference

2 December 2017

1 reference

2 December 2017

volume

82

1 reference

2 December 2017

issue

12

1 reference

2 December 2017

page(s)

1297-1303

1 reference

Beta-2 microglobulin in ESRD: an in-depth review

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta 2 microglobulin in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2012.301

1 reference

7 January 2021

A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

The MPO Study: just a European HEMO Study or something very different?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta2-microglobulin stimulates osteoclast formation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Uremia causes endothelial progenitor cell deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

The uremic retention solute p-cresyl sulfate and markers of endothelial damage.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Serum beta-2 microglobulin is a marker of high bone remodelling in elderly women

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

The central role of the propensity score in observational studies for causal effects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.301

7 January 2021

Identifiers

DOI

10.1038/KI.2012.301

1 reference

release_buqjtl6foba7dcwdhpt64ptw6q

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/buqjtl6foba7dcwdhpt64ptw6q

24 November 2022

mapped directly with Wikidata item

1 reference